繁體
简体中文
繁體中文

Cable One, Inc. CABO

交易中 11-04 09:57:46 美东时间

145.805

-0.425

-0.29%

华盛通華盛通
立即下載
  • 最 高146.00
  • 今 開144.00
  • 成交量 3888股
  • 最 低 144.00
  • 昨 收 146.23
  • 總市值 8.21亿
  • 52周最高 431.095
  • 市盈率 56.60
  • 換手率 0.07%
  • 52周最低 117.54
  • 委 比 3.90%
  • 總股本 562.90万
  • 歷史最高 2278.75
  • 量 比 1.39
  • 振 幅 1.37%
  • 歷史最低 117.54
  • 每 手 1
  • 風險率 93.02%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Sirius XM Holdings Earnings Preview

    Sirius XM Holdings (NASDAQ:SIRI) will release its quarterly earnings report on ...

    10-30 03:02

  • Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025

    Cabaletta Bio announced positive clinical data for rese-cel in treating patients with myositis, systemic sclerosis (SSc), and lupus. In the Phase 1/2 DM/ASyS cohort, all patients meeting inclusion criteria achieved major clinical responses without immunomodulators. A registrational trial for DM/ASyS is planned with 14 patients and a 16-week endpoint. In SSc, all patients with sufficient follow-up showed transformative responses off immunomodulato...

    10-27 11:00

  • Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant

    Cabaletta Bio appoints Steve Gavel as Chief Commercial Officer, who brings extensive CAR T experience from Legend Biotech. Gavel will lead global commercial strategy for rese-cel, with a BLA submission expected in 2027. He previously led the successful launch of CARVYKTI® at Legend Biotech and has a strong track record in commercializing cell therapies. The company anticipates Gavel's leadership will enhance the commercialization efforts for rese...

    10-14 12:00

  • Cabot Corporation Strengthens Manufacturing Capabilities in North America for Circular Reinforcing Carbons Powered by its EVOLVE® Sustainable Solutions Technology Platform

    Cabot Corporation expanded its North American circular reinforcing carbons manufacturing capabilities using tire pyrolysis oil (TPO) and ISCC PLUS certification, adding its Ville Platte site to join three global locations. This enhances its global network to 14 certified sites, supporting sustainable solutions and reducing emissions, while aligning with industry goals for 40% sustainable materials by 2030 and 100% by 2050. The EVOLVE® platform en...

    10-07 13:00

  • Cabot Corporation to Announce Fourth Quarter 2025 Operating Results

    Cabot Corporation announced that it will release its fourth-quarter 2025 results on November 3, 2025, after market close. A conference call and live webcast to review the results will be held on November 4 at 8:00 am ET. The webcast will be available on Cabot's website, with an archive and slide presentation accessible afterward. Cabot, headquartered in Boston, is a global leader in specialty chemicals and performance materials, including reinfor...

    10-03 12:16

  • Cabot Corporation Highlights Sustainability Progress in 2025 Sustainability Report

    Cabot Corporation has published its 2025 Sustainability Report, highlighting progress toward its 2025 goals, with 11 of 15 targets achieved ahead of schedule. Key achievements include community investments, new sustainable products, waste reduction, and GHG emissions intensity reduction. The company also unveiled its 2030 Sustainability Goals, focusing on six priority areas: GHG emissions, air quality, energy export, water conservation, product s...

    09-23 13:00

  • Insights into WideOpenWest's Upcoming Earnings

    WideOpenWest (NYSE:WOW) will release its quarterly earnings report on Monday, 2...

    08-09 03:03

  • Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update

    Cabaletta Bio announced plans to initiate registration cohorts for rese-cel in myositis by late 2025 and anticipates a 2027 BLA submission. Five disease-specific cohorts in the RESET program have completed enrollment, with expansion ongoing across multiple autoimmune diseases. The company also highlighted positive clinical data at the EULAR 2025 Congress, showing significant patient responses without immunomodulators or steroids. Furthermore, the...

    08-07 11:30

  • Cabot Corporation to Acquire Mexico Carbon Manufacturing S.A. de C.V. from Bridgestone Corporation

    Cabot Corporation has agreed to acquire Mexico Carbon Manufacturing (MXCB) from Bridgestone Corporation for $70 million. The facility, operational since 2005, will enhance Cabot's reinforcing carbon production and strengthen its partnership with Bridgestone. The acquisition aligns with Cabot's strategy to expand core markets and support long-term growth. The deal is subject to regulatory approval and expected to close within three to six months.

    08-04 20:30

  • Wells Fargo Maintains Underweight on Cable One, Lowers Price Target to $120

    Wells Fargo analyst Steven Cahall maintains Cable One (NYSE:CABO) with a Underweight and lowers the price target from $210 to $120.

    08-01 22:39